Astrana Health, Inc.
ASTH
$40.81
$3.027.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 60.53% | -13.64% | -47.89% | -84.73% | -63.08% |
| Total Depreciation and Amortization | 116.27% | 83.22% | 63.82% | 51.70% | 34.02% |
| Total Amortization of Deferred Charges | 73.14% | 118.00% | 121.55% | 94.08% | 76.26% |
| Total Other Non-Cash Items | -28.28% | 2.15% | 5.83% | 349.21% | 163.61% |
| Change in Net Operating Assets | -248.54% | 164.79% | 95.13% | 137.74% | 151.70% |
| Cash from Operations | -17.38% | 164.17% | 119.54% | 29.22% | 104.42% |
| Capital Expenditure | -44.85% | -2.83% | -25.84% | 23.76% | 35.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1,643.78% | -473.79% | -275.09% | -393.74% | 73.92% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 643.01% | 215.99% | 151.73% | 143.40% | 93.64% |
| Cash from Investing | -1,112.86% | -335.92% | -180.15% | -235.06% | 77.24% |
| Total Debt Issued | 71.03% | 49.26% | 551.23% | 146.95% | -8.73% |
| Total Debt Repaid | 62.48% | 82.50% | -1,731.55% | -126.16% | -107.38% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -228.03% | -124.06% | -285.75% | -60.47% | -66.82% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 60.87% | 42.77% | -8,818.95% | 89.59% | 89.97% |
| Other Financing Activities | 49.09% | 70.90% | -516.00% | -295.66% | -286.11% |
| Cash from Financing | 804.58% | 3,986.54% | 321.28% | 257.39% | -143.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 354.31% | 393.84% | 2,969.63% | 55.59% | -54.58% |